PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Recombinant thrombomodulin protects against LPS-induced acute respiratory distress syndrome via preservation of pulmonary endothelial glycocalyx.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32497259 ↗2020Reported benefit

Recombinant thrombomodulin protects against LPS-induced acute respiratory distress syndrome via preservation of pulmonary endothelial glycocalyx.

MouseEndotoxin/LPSC57BL/6Malen = Survival cohort of 80 control mice reported (52/80 alive at…Intraperitoneal injection30 mg/kg3 and 24 hours after LPS injection

Model: Lipopolysaccharide-induced endotoxaemia and acute respiratory distress syndrome, LPS 20 mg/kg intraperitoneally after 16 hours starvation

rhTM improved survival relative to controls at 48 hours after LPS, lowered serum IL-6 and HMGB1, attenuated pulmonary capillary endothelial glycocalyx injury and preserved glycocalyx synthesis gene and protein expression.

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.